A Study in Participants With Diabetic Kidney Disease
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if LY2382770 is safe and effective at protecting
kidney function in participants with kidney disease due to diabetes.